Income statement
CAD
Annual
| Metric | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|
| Revenue | 19M | 16M | 38K | 0 |
| Gross Profit | 8M | 7M | 26K | 0 |
| Operating Income | -28M | -14M | -6M | -2M |
| EBITDA | -25M | -17M | -5M | -2M |
| Net Income | -29M | -18M | -7M | -2M |
| EPS (Diluted) | — | — | — | — |
Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+900.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sunniva Inc. (SNNVF) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.00 and up 900.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of +16.9%, EPS growth of -51.7%, a dividend yield of 0.0%. What stands out right now is revenue +16.9%, EPS -51.7%, free cash flow -270.9% with operating margin -149.7% and ROIC -25.4%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines SNNVF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SNNVF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SNNVF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SNNVF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
-$1.9M
+72.2% YoY
Free Cash Flow
-$3.0M
+73.1% YoY
Revenue Growth
+16.9%
EPS Growth
-51.7%
Gross Margin
41.5%
Net Margin
-154.6%
Income statement
CAD
| Metric | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|
| Revenue | 19M | 16M | 38K | 0 |
| Gross Profit | 8M | 7M | 26K | 0 |
| Operating Income | -28M | -14M | -6M | -2M |
| EBITDA | -25M | -17M | -5M | -2M |
| Net Income | -29M | -18M | -7M | -2M |
| EPS (Diluted) | — | — | — | — |
Balance sheet
CAD
| Metric | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|
| Cash & Equivalents | 2M | 11M | 10M | 41K |
| Total Assets | 125M | 74M | 26M | 1M |
| Total Liabilities | 40M | 41M | 11M | 2M |
| Shareholder Equity | 85M | 33M | 14M | -755K |
| Total Debt | 24M | 30M | 10M | 2M |
| Net Debt | 22M | 18M | 56K | 2M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
3M
+34.4% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
3M
+73.1% YoY
Key ratios
Gross Margin
41.5%
Operating Margin
-149.7%
Net Margin
-154.6%
ROE
-48.7%
Debt / Equity
0.28x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.